| Date |
Research Question / Title |
Unique ID |
Research Team |
|
24-Apr-2020
|
How can LTC facilities prepare for a pandemic?
|
LTC042201-01 ESR
|
Long Term Care
|
|
April 25, 2020
|
What environmental management and built environment factors influence a home’s ability to prevent or manage an ILI outbreak? AND
What is the evidence for infection control practices (checklist items) for preventing or managing an ILI outbreak?
|
LTC042201-02 ESR
|
Long Term Care
|
|
April 28, 2020
|
What characteristics of residents in LTC homes affect the ability to provide routine care during a COVID-19 or ILI outbreak?
|
LTC042201-03 ESR
|
Long Term Care
|
|
April 29, 2020
|
How can LTC facilities prepare for a pandemic?
|
LTC042201 RR
|
Long Term Care
|
|
October 28, 2020
|
What is the evidence regarding limiting patient visitors in long-term care facilities to 2 or less, and how are other jurisdictions managing family caregivers?
|
LTC101501-01 ESR
|
Long Term Care
|
|
November 6, 2020
|
What is the evidence to support the reprocessing and re-use of N95 respirators by healthcare workers?
|
PPE110201-01 ESR
|
Personal Protective Equipment
|
|
November 6, 2020
|
What surveillance strategy is most effective for COVID-19 testing in healthcare workers?
|
EOC110401-01 ESR
|
EOC
|
|
November 10, 2020
|
What surveillance strategy is most effective for COVID-19 testing in healthcare workers?
|
EOC110401 RR
|
EOC
|
|
November 20, 2020
|
What is the evidence to support the reprocessing and re-use of N95 respirators by healthcare workers?
|
PPE110201 RR
|
Personal Protective Equipment
|
|
December 4, 2020
|
What is the evidence regarding limiting patient visitors in long-term care facilities to 2 or less, and how are other jurisdictions managing family caregivers?
|
LTC101501 RR
|
Long Term Care
|
|
January 13, 2021
|
What evidence is available to inform vaccination planning in congregate living?
|
EOC011102-01 ESR
|
EOC
|
|
January 15, 2021
|
What evidence is available to inform vaccination planning in congregate living?
|
EOC011102 RR
|
EOC
|
|
March 4, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401-01 ESR
|
Public Health
|
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
|
April 1, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 ESR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR Table
|
EOC
|
|
July 16, 2021
|
What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies?
|
INF210701 ESR
|
Infectious Disease
|
|
November 26, 2021
|
What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs?
|
EOC211126 ESR
|
EOC
|
|
November 30, 2021
|
What are the risks associated with repeated exposure to Ethylene Oxide from ongoing use of the Abbott Panbio AG COVID-19 Nasal swabs?
|
EOC211126 RR Table
|
EOC
|
